Acknowledgements
Editorial support was provided by Eva Kane, PhD, and Mary-Clare Cathcart, PhD, of Fishawack Indicia Ltd., part of Avalere Health, and was funded by GSK. This study was funded by GSK (213403; NCT04581824). The trial was designed by GSK, in collaboration with the authors. The sponsor provided support for the statistical analyses of the data and funded a medical writer for the report. Authors performed the data collection, analysis, and interpretation of the data. The authors had the final decision to submit the manuscript for publication. The manuscript was written by the authors with medical writing assistance funded by GSK. GSK had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. GSK collaborated with the investigators in designing the trial, provided the study drug, coordinated the management of the study sites, funded the statistical analysis, and provided medical writing support. Authors employed by GSK, in coordination with all authors, were involved in preparation, review, approval, and decision to submit the manuscript.